Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene - PubMed (original) (raw)
. 2003 Sep 1;63(17):5320-8.
Lino Tessarollo, Seung-Beom Hong, Masaya Baba, Eileen Southon, Timothy C Back, Sally Spence, Corrinne G Lobe, Nirmala Sharma, Gregory W Maher, Svetlana Pack, Alexander O Vortmeyer, Chuanfa Guo, Berton Zbar, Laura S Schmidt
Affiliations
- PMID: 14500363
Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene
Wenbin Ma et al. Cancer Res. 2003.
Abstract
von Hippel-Lindau (VHL) disease is a multisystem inherited cancer syndrome characterized by the development of highly vascular tumors including hemangioblastomas of the retina and central nervous system, pheochromocytomas, and clear cell renal carcinoma, which result from somatic inactivation of the wild-type VHL allele in cells harboring a germ-line VHL mutation. Homozygous inactivation of the VHL gene in mice resulted in embryonic lethality. To produce a mouse model that closely mimics human VHL disease and avoids embryonic lethality, we used Cre/lox site-specific recombination technology. We generated mice carrying conditional VHL alleles and a cre transgene under the control of the human beta-actin promoter, which directs cre expression in a mosaic pattern in multiple organs. VHL(f/d)/Cre mice developed multiple, hepatic hemangiomas that led to premature death, as well as angiectasis and angiogenesis in multiple organs. Interestingly, testes of male VHL(f/d)/Cre mice were unusually small with severely reduced sperm count resulting in infertility. Loss of pVHL function in this VHL conditional knockout mouse model results in an extensive abnormal vascular phenotype in multiple mouse organs, which will provide a useful animal model for testing potential antiangiogenic therapies for VHL disease treatment. Importantly, the phenotypic defects in sperm development observed in these mice support a novel role for VHL in spermatogenesis. This VHL conditional knockout mouse model will provide an in vivo system for studying the functional requirement of the VHL gene in reproductive biology.
Similar articles
- Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice.
Kleymenova E, Everitt JI, Pluta L, Portis M, Gnarra JR, Walker CL. Kleymenova E, et al. Carcinogenesis. 2004 Mar;25(3):309-15. doi: 10.1093/carcin/bgh017. Epub 2003 Nov 6. Carcinogenesis. 2004. PMID: 14604887 - Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.
Rankin EB, Tomaszewski JE, Haase VH. Rankin EB, et al. Cancer Res. 2006 Mar 1;66(5):2576-83. doi: 10.1158/0008-5472.CAN-05-3241. Cancer Res. 2006. PMID: 16510575 Free PMC article. - Inactivation of the tumor suppressor gene von Hippel-Lindau (VHL) in granulocytes contributes to development of liver hemangiomas in a mouse model.
Bader HL, Hsu T. Bader HL, et al. BMC Cancer. 2016 Oct 12;16(1):797. doi: 10.1186/s12885-016-2802-3. BMC Cancer. 2016. PMID: 27733136 Free PMC article. - von Hippel-Lindau disease: recent advances and therapeutic perspectives.
Richard S; French VHL Study Group. Richard S, et al. Expert Rev Anticancer Ther. 2003 Apr;3(2):215-33. doi: 10.1586/14737140.3.2.215. Expert Rev Anticancer Ther. 2003. PMID: 12722881 Review. - Conditional mouse models of sporadic cancer.
Jonkers J, Berns A. Jonkers J, et al. Nat Rev Cancer. 2002 Apr;2(4):251-65. doi: 10.1038/nrc777. Nat Rev Cancer. 2002. PMID: 12001987 Review.
Cited by
- Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastoma.
Park S, Chan CC. Park S, et al. Histol Histopathol. 2012 Aug;27(8):975-84. doi: 10.14670/HH-27.975. Histol Histopathol. 2012. PMID: 22763871 Free PMC article. Review. - Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice.
Rankin EB, Higgins DF, Walisser JA, Johnson RS, Bradfield CA, Haase VH. Rankin EB, et al. Mol Cell Biol. 2005 Apr;25(8):3163-72. doi: 10.1128/MCB.25.8.3163-3172.2005. Mol Cell Biol. 2005. PMID: 15798202 Free PMC article. - A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo.
Minamishima YA, Moslehi J, Padera RF, Bronson RT, Liao R, Kaelin WG Jr. Minamishima YA, et al. Mol Cell Biol. 2009 Nov;29(21):5729-41. doi: 10.1128/MCB.00331-09. Epub 2009 Aug 31. Mol Cell Biol. 2009. PMID: 19720742 Free PMC article. - Elongin B is a binding partner of the male germ cell nuclear speckle protein sperm-associated antigen 16S (SPAG16S) and is regulated post-transcriptionally in the testis.
Zhang Z, Huang Q, Wang Z, Zou J, Yu Z, Strauss Iii JF, Zhang Z. Zhang Z, et al. Reprod Fertil Dev. 2019 Apr;31(5):962-971. doi: 10.1071/RD18303. Reprod Fertil Dev. 2019. PMID: 30811962 Free PMC article. - Vhl deletion in renal epithelia causes HIF-1α-dependent, HIF-2α-independent angiogenesis and constitutive diuresis.
Schönenberger D, Rajski M, Harlander S, Frew IJ. Schönenberger D, et al. Oncotarget. 2016 Sep 20;7(38):60971-60985. doi: 10.18632/oncotarget.11275. Oncotarget. 2016. PMID: 27528422 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Molecular Biology Databases
Miscellaneous